Patient Guide: Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 27 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03677154
Status: COMPLETED
Condition: Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 27 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Santa Monica, California
  • Fort Wayne, Indiana
  • • And 24 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily